Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Bpom prohiper methylphenidate?

See the DrugPatentWatch profile for methylphenidate

The Indonesian National Agency of Drug and Food Control (BPOM) has prohibited the use of methylphenidate, a central nervous system stimulant, in certain products. This prohibition specifically targets products that claim to offer weight loss benefits or are marketed for athletic performance enhancement, due to the inherent risks associated with the drug's misuse and potential side effects [1].

Why did BPOM ban methylphenidate in weight loss and sports products?


BPOM's action stems from the classification of methylphenidate as a controlled substance due to its stimulant properties and potential for abuse. The drug is primarily prescribed for treating Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. Its inclusion in weight loss products is concerning because it can suppress appetite and increase metabolism, leading to adverse health outcomes. Similarly, its use for athletic enhancement is prohibited due to performance-altering effects and significant health risks, including cardiovascular issues and psychological dependence [1].

What are the risks of methylphenidate when used improperly?


When methylphenidate is used outside of its prescribed medical indications, particularly in high doses or for non-medical purposes, it can lead to serious health consequences. These risks include cardiovascular problems such as increased heart rate and blood pressure, neurological effects like anxiety and insomnia, and psychological issues including addiction and psychosis. The BPOM's prohibition aims to prevent these dangers by removing the drug from unregulated product formulations [1].

Where is methylphenidate typically prescribed?


Methylphenidate is a prescription medication approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adults, and for narcolepsy. Its use is strictly regulated to ensure patient safety and to prevent diversion for illicit purposes [1].

What is the legal status of methylphenidate in Indonesia?


In Indonesia, methylphenidate is a controlled substance. Its distribution and use are managed under strict regulations to prevent misuse. The recent BPOM prohibition on its use in weight loss and sports enhancement products reinforces these controls and highlights the agency's commitment to public health and safety [1].

Where can I find official information on BPOM regulations?


Official information regarding BPOM regulations, including pronouncements on controlled substances and product prohibitions, can be found on the BPOM website [1].

Source:
1. DrugPatentWatch.com



Other Questions About Methylphenidate :

who makes methylphenidate methylphenidate hydrochloride. is methylphenidate an amphetamine serdexmethylphenidate/dexmethylphenidate methylphenidate (ritalin) manufacturing plant cost Methylphenidate price increase? Methylphenidate generic manufacturers?